三氧疗法在卒中后肺炎康复治疗中的潜在作用

doi:10.3969/j.issn.1006-9771.2021.06.009

摘要/Abstract

摘要：

肺炎是最常见的卒中后感染类型，发病率达57%，且与卒中后不良预后独立相关。医用三氧作为一种新型无副作用的疗法，通过激活多种分子机制，实现免疫调节、抗炎、抗氧化应激、改善氧代谢等作用，可能为卒中后肺炎提供潜在治疗方法。

Abstract:

Pneumonia is the most common type of post-stroke infection, with an incidence of up to 57%, and is independently associated with poor outcome after stroke. Ozone is a harmless therapy working for anti-inflammatory, anti-oxidative stress and improving oxygenation through various molecular ways, which may be a potential therapy for post-stroke pneumonia.

Key words: ozone therapy, post-stroke pneumonia, mechanisms, review

中图分类号:

R743

张倩,席家宁. 三氧疗法在卒中后肺炎康复治疗中的潜在作用[J]. 《中国康复理论与实践》, 2021, 27(6): 687-691.

Qian ZHANG,Jia-ning XI. Potential of Ozone Therapy for Post-stroke Pneumonia (review)[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2021, 27(6): 687-691.

参考文献 57

1	O'DONNELL M J, CHIN S L, RANGARAJAN S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study [J]. Lancet, 2016, 388(10046): 761-775.
2	KRISHNAN S, LAWRENCE C B. Old dog new tricks; revisiting how stroke modulates the systemic immune landscape [J]. Front Neurol, 2019, 10: 718.
3	VERMEIJ F H, SCHOLTE OP REIMER W J, de Man P, et al. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey [J]. Cerebrovasc Dis, 2009, 27(5): 465-471.
4	STANLEY D, MASON L J, MACKIN K E, et al. Translocation and dissemination of commensal bacteria in post-stroke infection [J]. Nat Med, 2016, 22(11): 1277-1284.
5	WESTENDORP W F, NEDERKOORN P J, VERMEIJ J D, et al. Post-stroke infection: a systematic review and meta-analysis [J]. BMC Neurol, 2011, 11: 110.
6	ELKIND M S V, BOEHME A K, SMITH C J, et al. Infection as a stroke risk factor and determinant of outcome after stroke [J]. Stroke, 2020, 51(10): 3156-3168.
7	MEISEL C, SCHWAB J M, PRASS K, et al. Central nervous system injury-induced immune deficiency syndrome [J]. Nat Rev Neurosci, 2005, 6(10): 775-786.
8	HAEUSLER K G, SCHMIDT W U, FÖHRING F, et al. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans [J]. Cerebrovasc Dis, 2008, 25(1-2): 50-58.
9	BADVE M S, ZHOU Z, ANDERSON C S, et al. Effectiveness and safety of antibiotics for preventing pneumonia and improving outcome after acute stroke: systematic review and meta-analysis [J]. J Stroke Cerebrovasc Dis, 2018, 27(11): 3137-3147.
10	LIU L, XIONG X Y, ZHANG Q, et al. The efficacy of prophylactic antibiotics on post-stroke infections: an updated systematic review and meta-analysis [J]. Sci Rep, 2016, 6: 36656.
11	BOCCI V A. Scientific and medical aspects of ozone therapy. State of the art [J]. Arch Med Res, 2006, 37(4): 425-435.
12	SMITH N L, WILSON A L, GANDHI J, et al. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility [J]. Med Gas Res, 2017, 7(3): 212-219.
13	BOCCI V, ZANARDI I, TRAVAGLI V. Ozone: a new therapeutic agent in vascular diseases [J]. Am J Cardiovasc Drugs, 2011, 11(2): 73-82.
14	BOCCI V. How a calculated oxidative stress can yield multiple therapeutic effects [J]. Free Radic Res, 2012, 46(9): 1068-1075.
15	BRAIDY N, IZADI M, SUREDA A, et al. Therapeutic relevance of ozone therapy in degenerative diseases: focus on diabetes and spinal pain [J]. J Cell Physiol, 2018, 233(4): 2705-2714.
16	AMELI J, BANKI A, KHORVASH F, et al. Mechanisms of pathophysiology of blood vessels in patients with multiple sclerosis treated with ozone therapy: a systematic review [J]. Acta Biomed, 2019, 90(3): 213-217.
17	TIRELLI U, CIRRITO C, PAVANELLO M, et al. Ozone therapy in 65 patients with fibromyalgia: an effective therapy [J]. Eur Rev Med Pharmacol Sci, 2019, 23(4): 1786-1788.
18	GÜÇLÜ A, ERKEN H A, ERKEN G, et al. The effects of ozone therapy on caspase pathways, TNF-α, and HIF-1α in diabetic nephropathy [J]. Int Urol Nephrol, 2016, 48(3): 441-450.
19	IZADI M, KHEIRJOU R, MOHAMMADPOUR R, et al. Efficacy of comprehensive ozone therapy in diabetic foot ulcer healing [J]. Diabetes Metab Syndr, 2019, 13(1): 822-825.
20	FITZPATRICK E, HOLLAND O J, VANDERLELIE J J. Ozone therapy for the treatment of chronic wounds: a systematic review [J]. Int Wound J, 2018, 15(4): 633-644.
21	WANG X. Emerging roles of ozone in skin diseases [J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2018, 43(2): 114-123.
22	SONG M, ZENG Q, XIANG Y, et al. The antibacterial effect of topical ozone on the treatment of MRSA skin infection [J]. Mol Med Rep, 2018, 17(2): 2449-2455.
23	ISLER S C, UNSAL B, SOYSAL F, et al. The effects of ozone therapy as an adjunct to the surgical treatment of peri-implantitis [J]. J Periodontal Implant Sci, 2018, 48(3): 136-151.
24	BILGE A, ÖZTÜRK Ö, ADALI Y, et al. Could ozone treatment be a promising alternative for osteomyelitis? An experimental study [J]. Acta Ortop Bras, 2018, 26(1): 67-71.
25	SCASSELLATI C, CIANI M, GALOFORO A C, et al. Molecular mechanisms in cognitive frailty: potential therapeutic targets for oxygen-ozone treatment [J]. Mech Ageing Dev, 2020, 186: 111210.
26	ZENG J, LU J. Mechanisms of action involved in ozone-therapy in skin diseases [J]. Int Immunopharmacol, 2018, 56: 235-241.
27	BOCCI V, ZANARDI I, TRAVAGLI V. Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects [J]. Med Gas Res, 2011, 1(1): 6.
28	SAGAI M, BOCCI V. Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress? [J]. Med Gas Res, 2011, 1: 29.
29	GULMEN S, KURTOGLU T, METEOGLU I, et al. Ozone therapy as an adjunct to vancomycin enhances bacterial elimination in methicillin resistant Staphylococcus aureus mediastinitis [J]. J Surg Res, 2013, 185(1): 64-69.
30	CALISKAN B, GUVEN A, OZLER M, et al. Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis [J]. Scand J Clin Lab Invest, 2011, 71(6): 473-480.
31	ELVIS A M, EKTA J S. Ozone therapy: a clinical review [J]. J Nat Sci Biol Med, 2011, 2(1): 66-70.
32	ORAKDOGEN M, USLU S, EMON S T, et al. The effect of ozone therapy on experimental vasospasm in the rat femoral artery [J]. Turk Neurosurg, 2016, 26(6): 860-865.
33	MADEJ P, PLEWKA A, MADEJ J A, et al. Ozonotherapy in an induced septic shock. I. Effect of ozonotherapy on rat organs in evaluation of free radical reactions and selected enzymatic systems [J]. Inflammation, 2007, 30(1-2): 52-58.
34	SMITH-GARVIN J E, KORETZKY G A, JORDAN M S. T cell activation [J]. Annu Rev Immunol, 2009, 27: 591-619.
35	GROEGER G, QUINEY C, COTTER T G. Hydrogen peroxide as a cell-survival signaling molecule [J]. Antioxid Redox Signal, 2009, 11(11): 2655-2671.
36	AHMED S M, LUO L, NAMANI A, et al. Nrf2 signaling pathway: Pivotal roles in inflammation [J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(2): 585-597.
37	BOCCI V A, ZANARDI I, TRAVAGLI V. Ozone acting on human blood yields a hormetic dose-response relationship [J]. J Transl Med, 2011, 9: 66.
38	BOCCI V, ZANARDI I, HUIJBERTS M S, et al. Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy [J]. Diabetes Metab Syndr, 2011, 5(1): 45-49.
39	LEÓN FERNÁNDEZ O S, AJAMIEH H H, BERLANGA J, et al. Ozone oxidative preconditioning is mediated by A1 adenosine receptors in a rat model of liver ischemia/ reperfusion [J]. Transpl Int, 2008, 21(1): 39-48.
40	FORESTI R, BAINS S, SULC F, et al. The interaction of nitric oxide with distinct hemoglobins differentially amplifies endothelial heme uptake and heme oxygenase-1 expression [J]. J Pharmacol Exp Ther, 2006, 317(3): 1125-1133.
41	HUFFNAGLE G B, DICKSON R P, LUKACS N W. The respiratory tract microbiome and lung inflammation: a two-way street [J]. Mucosal Immunol, 2017, 10(2): 299-306.
42	SHIM R, WONG C H. Ischemia, immunosuppression and infection: tackling the predicaments of post-stroke complications [J]. Int J Mol Sci, 2016, 17(1): 64.
43	RUSSO T A, DAVIDSON B A, BEANAN J M, et al. Capsule and O-antigen from an extraintestinal isolate of Escherichia coli modulate cytokine levels in rat macrophages in vitro and in a rat model of pneumonia [J]. Exp Lung Res, 2007, 33(7): 337-356.
44	DOMSCHEIT H, HEGEMAN M A, CARVALHO N, et al. Molecular dynamics of lipopolysaccharide-induced lung injury in rodents [J]. Front Physiol, 2020, 11: 36.
45	GUIJARRO-MUÑOZ I, COMPTE M, ÁLVAREZ-CIENFUEGOS A, et al. Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway and proinflammatory response in human pericytes [J]. J Biol Chem, 2014, 289(4): 2457-2468.
46	Kim D W, Lenzen G, Page A L, et al. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes [J]. Proc Natl Acad Sci U S A, 2005, 102(39): 14046-14051.
47	ZURAWSKI D V, MUMY K L, FAHERTY C S, et al. Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein [J]. Mol Microbiol, 2009, 71(2): 350-368.
48	CROXEN M A, FINLAY B B. Molecular mechanisms of Escherichia coli pathogenicity [J]. Nat Rev Microbiol, 2010, 8(1): 26-38.
49	BENGOECHEA J A, PESSOA J SA. Klebsiella pneumoniae infection biology: living to counteract host defences [J]. FEMS Microbiol Rev, 2019, 43(2): 123-144.
50	GELLATLY S L, HANCOCK R E. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses [J]. Pathog Dis, 2013, 67(3): 159-173.
51	RIQUELME S A, AHN D, PRINCE A. Pseudomonas aeruginosa and Klebsiella pneumoniae adaptation to innate immune clearance mechanisms in the lung [J]. J Innate Immun, 2018, 10(5-6): 442-454.
52	PRASS K, MEISEL C, HÖFLICH C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation [J]. J Exp Med, 2003, 198(5): 725-736.
53	HANNAWI Y, HANNAWI B, RAO C P, et al. Stroke-associated pneumonia: major advances and obstacles [J]. Cerebrovasc Dis, 2013, 35(5): 430-443.
54	CUI W, ZHANG Z, ZHANG P, et al. Nrf2 attenuates inflammatory response in COPD/emphysema: crosstalk with Wnt3a/β-catenin and AMPK pathways [J]. J Cell Mol Med, 2018, 22(7): 3514-3525.
55	ISHII Y, ITOH K, MORISHIMA Y, et al. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema [J]. J Immunol, 2005, 175(10): 6968-6975.
56	DELGADO-ROCHE L, RIERA-ROMO M, MESTA F, et al. Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients [J]. Eur J Pharmacol, 2017, 811: 148-154.
57	RE L, MARTÍNEZ-SÁNCHEZ G, BORDICCHIA M, et al. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result [J]. Eur J Pharmacol, 2014, 742: 158-162.

[1]	杨同念, 任杰, 肖辉. 儿童青少年身体活动对焦虑的效果：系统综述的系统综述[J]. 《中国康复理论与实践》, 2025, 31(8): 883-888.
[2]	叶绿, 陈悦琳, 刘雨霏. 儿童身体活动与脑健康的认知神经科学研究技术范式与进展：Scoping综述[J]. 《中国康复理论与实践》, 2025, 31(8): 889-895.
[3]	王晓锋, 胡梦巧, 汪嫣, 魏坤, 徐文竹, 任丹, 马晔. 外骨骼机器人辅助步态训练对脑卒中和脊髓损伤下肢功能康复效果的系统综述[J]. 《中国康复理论与实践》, 2025, 31(8): 914-921.
[4]	顾逸青, 程舒芃, 李勇强, 毛二莉, 励建安. 成年气管切开患者拔管的直接策略与堵管策略对比的系统综述[J]. 《中国康复理论与实践》, 2025, 31(6): 666-673.
[5]	吴晓晖, 蒋雷, 朱静茹, 解利辉. 深度学习在老年人轻度认知障碍诊断中应用的Scoping综述[J]. 《中国康复理论与实践》, 2025, 31(6): 674-681.
[6]	潘义, 厚双龙, 温晓妮. 经皮迷走神经刺激在成年人执行功能中应用的Scoping综述[J]. 《中国康复理论与实践》, 2025, 31(5): 520-528.
[7]	王梅, 朱文平. 身体活动干预2型糖尿病患者的健康效益：系统综述的系统综述[J]. 《中国康复理论与实践》, 2025, 31(5): 553-560.
[8]	叶绿, 常晶, 凌海润. 网络行为成瘾的运动干预效果：系统综述的系统综述[J]. 《中国康复理论与实践》, 2025, 31(4): 431-440.
[9]	朱志强, 徐巧玲, 邵雪云. 肥胖和超重儿童参与身体活动的健康效益：系统综述的系统综述[J]. 《中国康复理论与实践》, 2025, 31(3): 296-305.
[10]	蔡倩, 张溪, 苏海荣, 刘娜, 黄颖, 李际强, 夏金根, 郑德采. 吸气肌训练对脱机失败者脱机疗效的系统综述[J]. 《中国康复理论与实践》, 2025, 31(3): 306-313.
[11]	徐晓红, 钟晓珂, 孙思怡, 张祁, 程怀春. 轻度认知障碍老年人参与艺术治疗心理健康效益的系统综述[J]. 《中国康复理论与实践》, 2025, 31(2): 165-171.
[12]	王晓晓, 瞿璐, 王佳欣, 赵梅萍, 李沐紫, 刘巧云. 内感受功能评估工具的结构、内容与心理测量特性：基于COSMIN和ICF的Scoping综述[J]. 《中国康复理论与实践》, 2025, 31(2): 172-183.
[13]	段富文, 张倍齐, 李丽. 运动干预对运动相关性脑震荡预防作用的系统综述[J]. 《中国康复理论与实践》, 2025, 31(12): 1385-1397.
[14]	杨文睿, 崔思栋, 曾莉. 虚拟与增强现实对孤独症谱系障碍儿童青少年认知、情绪和适应性行为干预效果的系统综述[J]. 《中国康复理论与实践》, 2024, 30(9): 1026-1033.
[15]	周静, 张晓晓, 丁忠冰, 陈建超, 魏星星, 林姝琦. 智力与发展性残疾儿童言语与语言障碍康复的系统综述[J]. 《中国康复理论与实践》, 2024, 30(8): 894-902.